Institute for Neurodegenerative Disorders-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2022

  1. Trial of Prasinezumab in Early-Stage Parkinson's Disease

    New England Journal of Medicine, Vol. 387, Núm. 5, pp. 421-432